DO
UTHR icon

denkapparat Operations’s United Therapeutics UTHR Stock Holding History

denkapparat Operations’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Sell
1,582
-256
-14% -$144K 0.28% 130
2026
Q1 		$1.09M Hold
1,838
– – 0.45% 67
2025
Q4 		$896K Sell
1,838
-762
-29% -$355K 0.49% 62
2025
Q3 		$1.09M Hold
2,600
– – 0.7% 24
2025
Q2 		$747K Buy
2,600
+866
+50% +$259K 0.6% 54
2025
Q1 		$535K Buy
1,734
+616
+55% +$211K 0.57% 59
2024
Q4 		$394K Buy
+1,118
New +$411K 0.58% 58

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

denkapparat Operations's UTHR Position: Q2 2026 in Review

denkapparat Operations reduced its United Therapeutics (UTHR) stake by 14% in Q2 2026, selling an estimated $144K and leaving 1,582 shares worth $857K. The position accounts for 0.28% of the portfolio, ranked #130.

denkapparat Operations first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.09M in Q3 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • denkapparat Operations held 1,582 shares of United Therapeutics worth $857K as of Q2 2026.
  • denkapparat Operations sold 256 United Therapeutics shares in Q2 2026, an estimated $144K.
  • United Therapeutics made up 0.28% of denkapparat Operations's portfolio in Q2 2026, its #130 holding.
  • denkapparat Operations first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • denkapparat Operations's United Therapeutics position peaked at $1.09M in Q3 2025.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.